Former OBIO CAAP Company Vasomune Announces Multi-Million Dollar Co-Development Agreement

Former OBIO CAAP company Vasomune announced an innovative global Co-Development Agreement with AnGes Inc for the development and commercialization of therapeutics treating diseases associated with blood vessel dysfunction and destabilization.

Click here for more information.

Previous
Previous

Pre-Screened & Ready to Go ‘Top Notch’ Experienced Business Talent Available for Fall 2018

Next
Next

Mackenzie Innovation Institute: Innovation Procurement Case Study, Sept 13